You are here

  • Home
  • Archive
  • Volume 67, Issue 7
  • Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression

Article Text

Article menu
Download PDFPDF
Letter
Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression

https://doi.org/10.1136/ard.2007.081059

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests: None declared.

    • Funding: The Dutch Arthritis Association and Amgen (Seattle, Washington, USA) financially contributed to this work.

    • SV contributed to this work on behalf of the Utrecht Rheumatoid Arthritis Cohort study group.